Submission of copies of financial results published in newspapers.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma Ltd has submitted copies of newspaper advertisements containing its financial results for the fourth quarter and the financial year ended March 31, 2026. The results were published in Business Standard and Nava Telangana on May 23, 2026. This is a mandatory regulatory filing submitted to both NSE and BSE as per SEBI listing requirements. The actual financial numbers are contained in the published advertisements, with this filing serving as proof of public disclosure.
This is a routine compliance filing confirming that Q4 and FY26 financial results have been made publicly available through newspaper publications. No immediate share price impact is expected as this is a disclosure requirement rather than a material corporate development.